New Medicare Policy: Update for Skin Substitute Grafts
Medicare LCD Policy Update for the Application of Skin Substitute Grafts/CTPs When Used for the Treatment of DFUs and VLUs
April 25, 2024
• All 7 Part B Medicare Administrative Contractors released identical Proposed LCDs and accompanying Proposed LCAs for the use of skin substitutes/CTPs for treating DFUs and VLUs.
• At this time, these are only proposals that are now subject to comment.
• One of the proposals is that coverage only be allowed for skin substitute grafts/CTPs that have peer-reviewed, published evidence supporting their use.
• Another proposal is to not allow greater than four applications of a skin substitute graft/CTP within the episode of skin replacement therapy other than “in exceptional cases in which four applications is not sufficient for adequate wound healing.”
February 12, 2025
“They’re Here.”
Medicare LCD Policy Update for the Application of Skin Substitute Grafts/CTPs When Used for the Treatment of DFUs and VLUs goes into effect on February 12, 2025.
This webinar presented by Michael G. Warshaw, DPM, CPC on Wednesday, January 15, 2025 will provide the complete update regarding the application of skin substitutes/CTPs. Providers will learn the new rules and regulations enabling them to document properly to support the use of the correct CPT codes, in order to bill appropriately and avoid the wrath of the Medicare Administrative Contractors (ie. MACS).
https://www.cmeonline.com/refund-policy
Medical Professionals
The information contained in this presentation does not establish a standard of care, nor does it constitute legal advice.
The information is for general informational purposes only and is prepared from a perspective to aid in understanding the pathology.
In accordance with the Council on Podiatric Medical Education's Standards and Requirements for Approval of Providers of Continuing Education in Podiatric Medicine, any relevant financial relationships with commercial interests of faculty, planning committee, or any others who have influence over the content of this educational activity must be disclosed to program participants. There are no conflicts of interest to disclose for this program
Commercial Interests: No commercial interest provided financial support for this continuing education activity.
CME Online is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. CME Online has approved this activity for a maximum two (2) continuing education contact hours.